Press Release: Aridis : Aridis Provides Corporate Update
LOS GATOS, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC: ARDS) ("Aridis" or the "Company"), a biopharmaceutical company, today announced a corporate update on recent developments.
Read full article »
Aridis is a California-based biopharmaceutical company that discovers and develops novel anti-infective therapies for the treatment of respiratory infections.
Read more